Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
1.120
-0.070 (-5.88%)
Nov 20, 2024, 4:00 PM EST - Market closed
Heron Therapeutics Employees
Heron Therapeutics had 126 employees as of December 31, 2023. The number of employees decreased by 77 or -37.93% compared to the previous year.
Employees
126
Change (1Y)
-77
Growth (1Y)
-37.93%
Revenue / Employee
$1,093,151
Profits / Employee
-$221,960
Market Cap
170.35M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Cellectis | 221 |
Biodesix | 217 |
Caribou Biosciences | 158 |
Nkarta | 150 |
BrainsWay | 134 |
Senseonics Holdings | 132 |
Nanobiotix | 102 |
Inozyme Pharma | 59 |
HRTX News
- 8 days ago - Heron Therapeutics, Inc. (HRTX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance - PRNewsWire
- 16 days ago - Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors - PRNewsWire
- 22 days ago - Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024 - PRNewsWire
- 5 weeks ago - Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®, and APONVIE® as Alternatives During the Potential Shortage of Intravenous Fluids - PRNewsWire
- 2 months ago - Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") - PRNewsWire
- 2 months ago - Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer - PRNewsWire
- 3 months ago - Heron Therapeutics, Inc., (HRTX) Q2 2024 Earnings Call Transcript - Seeking Alpha